Eli Lilly just showed the world how to outfox the tariff chaos. Most European drugmakers have announced some sort of investment in the US since President Trump’s tariff threats began earlier this year, so his latest announcement appears largely toothless. But Eli Lilly seems to have successfully front-run any possible tariff trouble, based on this chart tracking its imports from Ireland, where its most lucrative drugs are made. sherwood.news/business/wh.. #Data is beautiful